Old Web
English
Sign In
Acemap
>
authorDetail
>
Beth Kamp
Beth Kamp
Tazemetostat
Internal medicine
Medicine
Phases of clinical research
Oncology
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tazemetostat (TAZ) in relapsed/refractory (R/R) follicular lymphoma (FL): Propensity-score matched analysis of E7438-G000-101 trial outcomes.
2021
Journal of Clinical Oncology
David Proudman
Deepshekhar Gupta
Dave Nellesen
Alex Wong
Jay Yang
Beth Kamp
Khalid Mamlouk
Show All
Source
Cite
Save
Citations (0)
IBCL-165: Tazemetostat in Relapsed/Refractory (R/R) Follicular Lymphoma (FL): Propensity Score-Matched Analysis of E7438-G000-101 Trial Outcomes
2021
Clinical Lymphoma, Myeloma & Leukemia
David Proudman
Deepshekhar Gupta
Dave Nellesen
Alex Wong
Jay Yang
Beth Kamp
Khalid Mamlouk
Bruce D. Cheson
Show All
Source
Cite
Save
Citations (0)
Analyzing Efficacy Outcomes from the Phase 2 Study of Single-Agent Tazemetostat As Third-Line Therapy in Patients with Relapsed or Refractory Follicular Lymphoma to Identify Predictors of Response
2020
Blood
Gilles Salles
Hervé Tilly
Aristeidis Chaidos
Pam McKay
Tycel J. Phillips
Sarit Assouline
Connie Lee Batlevi
Philip Campbell
Vincent Ribrag
Gandhi Damaj
Michael Dickinson
Wojciech Jurczak
Maciej Kaźmierczak
Stephen Opat
John Radford
Anna Schmitt
Jennifer Whalen
Anthony Hamlett
Beth Kamp
Deyaa Adib
Franck Morschhauser
Show All
Source
Cite
Save
Citations (1)
1